CCR5 N-terminal Region Plays a Critical Role in HIV-1 Inhibition by Toxoplasma gondii-derived Cyclophilin-18
Open Access
- 1 August 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (33) , 29570-29577
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Variants of Human Immunodeficiency Virus Type 1 That Efficiently Use CCR5 Lacking the Tyrosine-Sulfated Amino Terminus Have Adaptive Mutations in gp120, Including Loss of a Functional N-GlycanJournal of Virology, 2005
- Classic AIDS in a Sooty Mangabey after an 18-Year Natural InfectionJournal of Virology, 2004
- Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4AIDS, 2003
- HIV biological variability unveiledAIDS, 2003
- Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondiiBlood, 2003
- Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 ComplexesJournal of Virology, 2001
- Virally encoded 7TM receptorsOncogene, 2001
- Perspective: Research Highlights at the Aaron Diamond AIDS Research Center : The β-Chemokines, HIV Type 1 Second Receptors, and Exposed Uninfected PersonsAIDS Research and Human Retroviruses, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996